Share this article
Share this article
ResearchAndMarkets.com s offering.
Amid the COVID-19 crisis, the global market for Retinal Implants estimated at US$39.4 Million in the year 2020, is projected to reach a revised size of US$73 Million by 2027, growing at a CAGR of 9.2% over the analysis period 2020-2027.
Implantable Miniature Telescope, one of the segments analyzed in the report, is projected to record a 9.7% CAGR and reach US$41.8 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Argus II segment is readjusted to a revised 9.4% CAGR for the next 7-year period.
Retinitis Pigmentosa Treatment Management Market
atulpmrMay 16, 2021 1
The Retinitis Pigmentosa Treatment Management Market report by Persistence Market Research is focusing on the fact that healthcare providers are into collection of socioeconomic information of the patients, so that tracking at any point of time is possible. This on-the-go monitoring is amongst the ongoing trends in the healthcare industry.
Retinitis pigmentosa is a group of inherited retinal diseases that affects about 100,000 Americans and 1.5 million people worldwide. It is part of a group of rare genetic disorders that cause slow but progressive degeneration of photoreceptor cells in the retina.
RP symptoms typically begin in childhood with decreased night vision, followed by loss of peripheral vision, and can eventually lead to complete loss of vision. It causes the progressive deterioration of specialized, light-absorbing cells in the retina, the paper-thin tissue that lines the back of the eye like fi